Table 1 Respondent demographics (N = 449)
From: Gynecologic cancer survivor preferences for long-term surveillance
Age at Diagnosis | < 40 years | 40 (8.9%) |
40–49 years | 105 (23.4%) | |
50–59 years | 187 (41.6%) | |
60–69 years | 92 (20.5%) | |
≥70 years | 25 (5.6%) | |
Primary Site of Disease | Vulva/vagina | 8 (1.8%) |
Cervix | 30 (6.7%) | |
Endometrial/uterine/GTN | 115 (25.5%) | |
Ovary/fallopian tube/peritoneal | 296 (66.0%) | |
Area of Residence | Northeast/Mid-Atlantic | 100 (22.2%) |
South Atlantic | 82 (18.3%) | |
South Central | 45 (10.0%) | |
North Central | 130 (29.0%) | |
Mountain/Pacific | 82 (18.3%) | |
International | 9 (2.2%) | |
Insurance Coverage | Medicaid/Medicare | 98 (22.2%) |
PPO/HMO | 319 (72.2%) | |
Uninsured | 8 (1.8%) | |
Military/Other | 17 (3.8%) | |
Physicians involved in care | Gynecologic Oncologist | 429 (95.5%) |
Medical Oncologist | 139 (31.0%) | |
Radiation Oncologist | 94 (20.9%) | |
Other/unsure | 86 (19.2%) | |
Distance to oncologist’s office | ≤20 miles | 240 (54.7%) |
21–50 miles | 127 (28.4%) | |
51–100 miles | 41 (9.3%) | |
> 100 miles | 31 (7.1%) | |
How convenient to go to oncologist’s office? | Very convenient | 166 (37.6%) |
Slightly convenient | 43 (9.7%) | |
Neither convenient nor inconvenient | 38 (8.6%) | |
Slightly inconvenient | 108 (24.4%) | |
Very inconvenient | 87 (19.7%) | |
Which office is closer to your residence? | Oncologist | 37 (8.4%) |
OB/GYN | 109 (24.8%) | |
Oncologist and OB/GYN equidistant | 132 (30.1%) | |
Don’t have OB/GYN | 161 (36.7%) |